Healthcare & Life Sciences
AbFero Pharmaceuticals Inc
United Statesabferopharmaceuticals.com
acquiredacquired
acquired
Stage
About
AbFero Pharmaceuticals Inc. is a clinical stage pharmaceutical company developing oral iron chelators, including their brain-penetrant small molecule SP-420, to treat diseases caused by systemic and local iron overload such as transfusional iron overload and age-related macular degeneration.
Explore AbFero Pharmaceuticals Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.